Figure 1From: Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective studyVirological, serological and biochemical response over time. The rates of VR, accumulative HBeAg loss, HBeAg seroconversion increased with time.Back to article page